蛋白/疫苗制剂

Comparison of Strategies in Development and Manufacturing of Low Viscosity, Ultra-High Concentration Formulation for IgG1 Antibody.

Comparison of Strategies in Development and Manufacturing of Low Viscosity, Ultra-High Concentration Formulation for IgG1 Antibody.

Formulating monoclonal antibodies as powders for reconstitution at high concentration using spray-drying: Trehalose/amino acid combinations as reconstitution time reducing and stability improving formulations.

Advancing predictions of protein stability in the solid state

Ectoine and Hydroxyectoine Stabilize Antibodies in Spray-Dried Formulations at Elevated Temperature and during a Freeze/Thaw Process

Hydroxypropyl beta cyclodextrin: a water-replacement agent or a surfactant upon spray freeze-drying of IgG with enhanced stability and aerosolization

Comparing freeze drying and spray drying of interleukins using model protein CXCL8 and its variants

Chaperone Networks in Fungal Pathogens of Humans

Electrostatic spray drying for monoclonal antibody formulation.

Local Treatment of Non-small Cell Lung Cancer with a Spray-Dried Bevacizumab Formulation

Identification of Stability Constraints in the Particle Engineering of an Inhaled Monoclonal Antibody Dried Powder.

Development of a formulation platform for a spray-dried, inhalable tuberculosis vaccine candidate.

New GMP manufacturing processes to obtain thermostable HIV-1 gp41 virosomes under solid forms for various mucosal vaccination routes

Single-administration, thermostable human papillomavirus vaccines prepared with atomic layer deposition technology

Evaluation of the stability of a spray-dried tuberculosis vaccine candidate designed for dry powder respiratory delivery.

Electrostatic spray drying for monoclonal antibody formulation.

Chemical (neo)glycosylation of biological drugs.

Microparticle encapsulation of a tuberculosis subunit vaccine candidate containing a nanoemulsion adjuvant via spray drying.

Thorough overview of ubiquitin C‐terminal hydrolase‐L1 and glial fibrillary acidic protein as tandem biomarkers recently cleared by US Food and Drug Administration for the evaluation of intracranial injuries among patients with traumatic brain injury

Recent advances in proteolytic stability for peptide, protein, and antibody drug discovery